Aghazadeh Behzad
Director
PurchaseAlert
- Shares
- 7,905
- Price
- $18.25
- Value
- $144,266
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•25 filings
SCTX
Scribe Therapeutics, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 2 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$71,344,746
14 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
9
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
2 executive purchases found
Get SCTX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SCTX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
35
Raw transactions
Everything returned by the filing
9
Voluntary view
P/S trades after deterministic checks
16
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 19,385
- Price
- $0.00
- Footnotes
- 4
The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering, and the transaction is reported herein pursuant to Rule 16a-2(a). The option is fully vested. The options will vest as to 1/48 of the total shares monthly over four years, with the first tranche scheduled to vest on August 23, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The options are eligible to vest upon the achievement of certain market-based performance criteria during a performance period beginning on July 23, 2026 and ending on July 23, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
AH Bio Fund II, L.P.
10% owner
PurchaseAlert
- Shares
- 333,333
- Price
- $15.00
- Value
- $4,999,995
GORDON CARL L
Director
PurchaseAlert
- Shares
- 1,000,000
- Price
- $15.00
- Value
- $15,000,000
ORBIMED ADVISORS LLC
Director
PurchaseAlert
- Shares
- 1,000,000
- Price
- $15.00
- Value
- $15,000,000
Aghazadeh Behzad
Director
PurchaseAlert
- Shares
- 50,000
- Price
- $22.31
- Value
- $1,115,500
Aghazadeh Behzad
Director
PurchaseAlert
- Shares
- 2,333,333
- Price
- $15.00
- Value
- $34,999,995
Parrot David
Chief Financial Officer
PurchaseAlert
- Shares
- 1,333
- Price
- $15.00
- Value
- $19,995
Parrot David
Chief Financial Officer
PurchaseAlert
- Shares
- 1,333
- Price
- $15.00
- Value
- $19,995
Lucas Svetlana
Chief Business Officer
PurchaseAlert
- Shares
- 3,000
- Price
- $15.00
- Value
- $45,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Aghazadeh Behzad Director | Purchase | 7,905 | $18.25 | $144,266 | |
| Jul 27, 2026 | AH Bio Fund II, L.P. 10% owner | Purchase | 333,333 | $15.00 | $4,999,995 | |
| Jul 27, 2026 | GORDON CARL L Director | Purchase | 1,000,000 | $15.00 | $15,000,000 | |
| Jul 27, 2026 | ORBIMED ADVISORS LLC Director | Purchase | 1,000,000 | $15.00 | $15,000,000 | |
| Jul 24, 2026 | Aghazadeh Behzad Director | Purchase | 50,000 | $22.31 | $1,115,500 | |
| Jul 24, 2026 | Aghazadeh Behzad Director | Purchase | 2,333,333 | $15.00 | $34,999,995 | |
| Jul 23, 2026 | Parrot David Chief Financial Officer | Purchase | 1,333 | $15.00 | $19,995 | |
| Jul 23, 2026 | Parrot David Chief Financial Officer | Purchase | 1,333 | $15.00 | $19,995 | |
| Jul 23, 2026 | Lucas Svetlana Chief Business Officer | Purchase | 3,000 | $15.00 | $45,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.